文献速递新发突发、热带与寄生虫病

肯尼亚婴儿急性发热性疟疾及蒿甲醚-苯芴醇治疗前后肠道菌群纵向分析

Longitudinal Analysis of Infant Stool Bacteria Communities Before and After Acute Febrile Malaria and Artemether-Lumefantrine Treatment.
PubMed 文献 · J Infect Dis · 2019-01-01

研究纳入100名肯尼亚婴儿进行主动疟疾监测,选取10名无抗生素干扰的婴儿,比较疟疾发作/蒿甲醚-苯芴醇治疗前后的粪便菌群16S rRNA基因测序。结果显示治疗前后菌群α/β多样性及分类组成无显著差异,仅1个序列变体有差异,但疟疾发作次数(1次 vs 2次)可解释菌群组成的显著变异。

要点

  • 疟疾发作及蒿甲醚-苯芴醇治疗对婴儿肠道菌群影响极小。
  • 疟疾发作次数(1次 vs 2次)与肠道菌群组成变异显著相关。
  • 研究提示疟疾不通过改变肠道菌群前奏导致菌血症。

核心结论

  • 疟疾发作/蒿甲醚-苯芴醇治疗对肯尼亚婴儿肠道菌群影响极小。

研究设计与样本

  • 对100名肯尼亚婴儿从出生至10月龄进行疟疾主动监测,每次发作均用蒿甲醚-苯芴醇治疗。
  • 选取10名无抗生素使用的婴儿,采集疟疾发作前(n=27)和发作后(n=17)的粪便样本。
  • 对样本进行16S rRNA基因V3-V4区测序分析。

主要发现

  • 菌群网络分析显示疟疾/蒿甲醚-苯芴醇治疗前后样本无肉眼可见差异。
  • α多样性和β多样性及科、属水平分类分析均无差异,仅1个例外。
  • 在序列变体水平,前100个序列变体中仅1个有显著差异。
  • 预测宏基因组分析显示治疗前后宏基因组能力无显著差异。
  • 疟疾发作次数(1次 vs 2次)可解释婴儿肠道菌群组成的显著变异。

临床怎么用

  • 临床对于疟疾婴儿,蒿甲醚-苯芴醇治疗对肠道菌群扰动小,无需因菌群影响而顾虑用药。
  • 疟疾发作次数可能影响肠道菌群组成,多次发作婴儿或需关注菌群变化。

局限性

  • 未明确报告序列变体差异的具体数值和P值。
  • 仅基于16S rRNA基因测序,预测宏基因组分析未验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Gut microbiota were recently shown to impact malaria disease progression and outcome, and prior studies have shown that Plasmodium infections increase the likelihood of enteric bacteria causing systemic infections. Currently, it is not known whether Plasmodium infection impacts human gut microbiota as a prelude to bacteremia or whether antimalarials affect gut microbiota. Our goal was to determine to what degree Plasmodium infections and antimalarial treatment affect human gut microbiota. METHODS: One hundred Kenyan infants underwent active surveillance for malaria from birth to 10 months of age. Each malaria episode was treated with artemether-lumefantrine (AL). Any other treatments, including antibiotics, were recorded. Stool samples were collected on an approximately biweekly basis. Ten children were selected on the basis of stool samples having been collected before (n = 27) or after (n = 17) a malaria episode and without antibiotics having been administered between collections. These samples were subjected to 16S ribosomal ribonucleic acid gene (V3-V4 region) sequencing. RESULTS: Bacterial community network analysis revealed no obvious differences in the before and after malaria/AL samples, which was consistent with no difference in alpha and beta diversity and taxonomic analysis at the family and genus level with one exception. At the sequence variant (SV) level, akin to bacterial species, only 1 of the top 100 SVs was significantly different. In addition, predicted metagenome analysis revealed no significant difference in metagenomic capacity between before and after malaria/AL samples. The number of malaria episodes, 1 versus 2, explained significant variation in gut microbiota composition of the infants. CONCLUSIONS: In-depth bioinformatics analysis of stool bacteria has revealed for the first time that human malaria episode/AL treatment have minimal effects on gut microbiota in Kenyan infants.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Mandal RK, Crane RJ, Berkley JA, et al. Longitudinal Analysis of Infant Stool Bacteria Communities Before and After Acute Febrile Malaria and Artemether-Lumefantrine Treatment. J Infect Dis. 2019. PMID: 30590681. doi:10.1093/infdis/jiy740

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。